(AXSM) Axsome Therapeutics - Performance 37% in 12m
AXSM performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
44.34%
#19 in Peer-Group
Rel. Strength
82.17%
#1357 in Stock-Universe
Total Return 12m
36.97%
#25 in Peer-Group
Total Return 5y
39.12%
#39 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 137.75 USD |
| 52 Week Low | 72.51 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 19.26 |
| Buy/Sell Signal +-5 | -1.35 |
| Support / Resistance | Levels |
|---|---|
| Support | 103.9, 99.9, 90.4, 83.8, 79.8 |
| Resistance | 107.1 |
12m Total Return: AXSM (37%) vs XLV (-5.1%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
-4.5% | 145% | 360% | 61.3 | 55.3 | 0.61 | 23.7% | -5.15% |
| LLY NYSE Eli Lilly |
12% | -6.78% | 514% | 66.1 | 37 | 1.24 | 58.2% | 18.9% |
| NVS NYSE Novartis |
10.1% | 17.9% | 81.6% | 18.5 | 14 | 1.37 | 8.70% | 9.2% |
| NOVN SW Novartis |
7.55% | 7.58% | 54.8% | 18.7 | 14.1 | 1.38 | 9.80% | 11.2% |
| SFZN SW Siegfried Holding |
-0.63% | 2.28% | 140% | 26.1 | 25 | 1.48 | 77.8% | 77.6% |
| GSK NYSE GlaxoSmithKline |
10% | 4.92% | 57.7% | 19.9 | 9.2 | 0.4 | -25.2% | 3.11% |
| AZN NASDAQ AstraZeneca |
9.51% | -4.27% | 58.6% | 28.9 | 15.9 | 0.96 | 52.7% | 22.3% |
| IPN PA Ipsen |
2.14% | -13% | 54.2% | 24.4 | 10.3 | 0.74 | -6.40% | -6.33% |
Performance Comparison: AXSM vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for AXSM
| Total Return (including Dividends) | AXSM | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -2.91% | 4.35% | 1.11% |
| 3 Months | -17.17% | -6.89% | 5.58% |
| 12 Months | 36.97% | -5.08% | 10.51% |
| 5 Years | 39.12% | 50.53% | 109.12% |
| Trend Score (consistency of price movement) | AXSM | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 23.9% | 65.8% | 69.9% |
| 3 Months | -26.6% | -72% | 69.3% |
| 12 Months | 82.2% | -62.2% | 43.2% |
| 5 Years | 55.8% | 88.5% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | #140 | -6.95% | -3.97% |
| 3 Month | #154 | -11.04% | -21.55% |
| 12 Month | #26 | 44.31% | 23.95% |
| 5 Years | #42 | -7.58% | -33.47% |
FAQs
Does Axsome Therapeutics (AXSM) outperform the market?
Yes,
over the last 12 months AXSM made 36.97%, while its related Sector, the Health Care Sector SPDR (XLV) made -5.08%.
Over the last 3 months AXSM made -17.17%, while XLV made -6.89%.
Performance Comparison AXSM vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
AXSM vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -4.8% | -4% | 17.1% | 26% |
| US NASDAQ 100 | QQQ | -4.6% | -4.4% | 17.9% | 28% |
| German DAX 40 | DAX | -2.6% | -2.2% | 0.7% | 8% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -4.5% | -2% | 15.3% | 25% |
| Hongkong Hang Seng | HSI | -5.3% | -8% | -1.9% | 10% |
| India NIFTY 50 | INDA | -3.1% | -1.6% | 18.1% | 38% |
| Brasil Bovespa | EWZ | -7.1% | -3.4% | -3.1% | 28% |
AXSM vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -4.5% | -4.4% | 14.3% | 14% |
| Consumer Discretionary | XLY | -4.3% | -1.1% | 27% | 19% |
| Consumer Staples | XLP | -4.5% | -2.7% | 15.6% | 30% |
| Energy | XLE | -10.7% | -5.8% | 13.5% | 34% |
| Financial | XLF | -3.2% | -0.3% | 14.3% | 13% |
| Health Care | XLV | -6.7% | -7.3% | 17.5% | 42% |
| Industrial | XLI | -3.8% | -3.3% | 11.5% | 19% |
| Materials | XLB | -4.1% | -4.3% | 16.3% | 38% |
| Real Estate | XLRE | -5.3% | -3.9% | 16.1% | 24% |
| Technology | XLK | -5.1% | -4.9% | 16.7% | 33% |
| Utilities | XLU | -6.2% | -3.4% | 8.7% | 16% |
| Aerospace & Defense | XAR | -3.8% | -8.7% | 0.1% | -6% |
| Biotech | XBI | -4.5% | -10.7% | 27.9% | 45% |
| Homebuilder | XHB | -3.2% | 2.1% | 32.5% | 46% |
| Retail | XRT | -0.9% | -2.7% | 25% | 36% |
AXSM vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -16.6% | -21.6% | 7.23% | 34% |
| Natural Gas | UNG | -4% | -0.3% | -1.2% | 52% |
| Gold | GLD | -8.4% | -9.1% | -13.1% | -10% |
| Silver | SLV | -4% | -14.3% | -2.5% | 15% |
| Copper | CPER | -2.3% | -4.6% | 2.2% | 29% |
AXSM vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -6.3% | -3.6% | 18.5% | 41% |
| iShares High Yield Corp. Bond | HYG | -5.3% | -3.4% | 13.4% | 28% |